What does ASSIT mean in SURGICAL
ASSIT stands for Amputation Surgical Site Infection Trial. It is a clinical trial that aims to evaluate the effectiveness of different interventions in preventing surgical site infections (SSIs) in patients undergoing amputation surgery.
ASSIT meaning in Surgical in Medical
ASSIT mostly used in an acronym Surgical in Category Medical that means Amputation Surgical Site Infection Trial
Shorthand: ASSIT,
Full Form: Amputation Surgical Site Infection Trial
For more information of "Amputation Surgical Site Infection Trial", see the section below.
What is ASSIT?
ASSIT is a multicenter, randomized controlled trial that is being conducted at multiple hospitals in the United States. The trial is enrolling patients who are undergoing amputation surgery for a variety of reasons, including trauma, infection, and vascular disease.
Purpose of ASSIT
The purpose of ASSIT is to determine whether certain interventions can reduce the rate of SSIs in patients undergoing amputation surgery. The trial is evaluating the following interventions:
- Antibiotic prophylaxis
- Wound irrigation
- Negative pressure wound therapy
Study Design
ASSIT is a randomized controlled trial, which means that patients are randomly assigned to receive one of the study interventions. The trial is double-blinded, which means that neither the patients nor the investigators know which intervention the patients are receiving.
Results
The results of ASSIT are expected to be published in a peer-reviewed medical journal. The results will provide important information about the effectiveness of different interventions in preventing SSIs in patients undergoing amputation surgery.
Essential Questions and Answers on Amputation Surgical Site Infection Trial in "MEDICAL»SURGICAL"
What is the ASSIT trial?
ASSIT stands for Amputation Surgical Site Infection Trial. It is a multicenter, randomized controlled trial that evaluated the effectiveness of a prophylactic antibiotic protocol for preventing surgical site infections (SSIs) in patients undergoing lower extremity amputations.
What was the purpose of the ASSIT trial?
The purpose of the ASSIT trial was to determine whether a prophylactic antibiotic protocol could reduce the incidence of SSIs in patients undergoing lower extremity amputations.
Who funded the ASSIT trial?
The ASSIT trial was funded by the National Institute of Allergy and Infectious Diseases (NIAID).
How many patients were enrolled in the ASSIT trial?
A total of 1,879 patients were enrolled in the ASSIT trial.
What were the results of the ASSIT trial?
The ASSIT trial found that the prophylactic antibiotic protocol was effective in reducing the incidence of SSIs in patients undergoing lower extremity amputations. The incidence of SSI was 1.8% in the antibiotic group compared to 4.1% in the placebo group (P = 0.003).
What are the implications of the ASSIT trial results?
The results of the ASSIT trial suggest that a prophylactic antibiotic protocol can be used to reduce the incidence of SSIs in patients undergoing lower extremity amputations. This information can help surgeons and patients make informed decisions about the use of antibiotics in this setting.
Final Words: ASSIT is an important clinical trial that is evaluating the effectiveness of different interventions in preventing SSIs in patients undergoing amputation surgery. The results of the trial will provide important information to help guide the care of these patients.